Tonix Pharmaceuticals Hol... (TNXP)
NASDAQ: TNXP
· Real-Time Price · USD
51.66
-7.92 (-13.29%)
At close: Aug 15, 2025, 1:03 PM
Tonix Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2M | 2.43M | 2.58M | 2.82M | 2.21M | 2.48M | -30.12M | 3.99M | n/a | 33.9M | n/a | n/a | 9.03M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 3.27M | 943K | 1.18M | 1.55M | 3.37M | 1.66M | -27.53M | 2.37M | 29M | 893K | 836K | n/a | 102K | 63K | 27K | 18.54M | 23.56M | 20.74M |
Gross Profit | -1.27M | 1.49M | 1.4M | 1.27M | -1.16M | 822K | -2.6M | 1.61M | -29M | 33.01M | -836K | n/a | 8.93M | -63K | -27K | -18.54M | -23.56M | -20.74M |
Operating Income | -28.3M | -16.05M | -22.48M | -15.55M | -18.36M | -21.35M | -27.33M | -28.15M | -29M | -33.9M | -32.73M | -29.59M | -23.34M | -26.4M | -29.56M | -18.54M | -23.56M | -20.74M |
Interest Income | 943K | n/a | n/a | n/a | n/a | n/a | -1.72M | 172K | 646K | 897K | 1.05M | 610K | 196K | 19K | 7K | 7K | 9K | 83K |
Pretax Income | -28.27M | -16.83M | -22.11M | -14.21M | -78.78M | -14.94M | -27.32M | -27.98M | -28.36M | -33.01M | -31.68M | -28.98M | -23.14M | -26.42M | -29.55M | -18.53M | -23.55M | -20.65M |
Net Income | n/a | -16.83M | -22.11M | -14.21M | -78.78M | -14.94M | -27.32M | -27.98M | -28.36M | -33.01M | -34.08M | -28.98M | -27.39M | -26.42M | -29.55M | -18.53M | -23.55M | -20.65M |
Selling & General & Admin | 16.2M | 10.1M | 15.58M | 7.71M | 7.5M | 9.31M | 11.62M | 8.71M | 7.03M | 7.39M | 8.05M | 7.39M | 6.76M | 8.01M | 7.26M | 5.45M | 5.43M | 5.41M |
Research & Development | 10.82M | 7.44M | 8.3M | 9.11M | 9.7M | 12.86M | 17.12M | 21.05M | 21.98M | 26.51M | 24.67M | 22.2M | 16.58M | 18.42M | 22.3M | 13.08M | 18.13M | 15.33M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -1.54M | n/a | 646K | 897K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 27.02M | 17.54M | 23.88M | 16.82M | 17.2M | 22.17M | 28.74M | 29.76M | 29M | 33.9M | 32.73M | 29.59M | 23.34M | 26.44M | 29.56M | 18.54M | 23.56M | 20.74M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 12.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 30.29M | 18.48M | 25.06M | 18.38M | 20.57M | 23.83M | 31.11M | 32.14M | 29M | 33.9M | 32.73M | 29.59M | 23.34M | 26.44M | 29.56M | 18.54M | 23.56M | 20.74M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.61M | n/a | -196K | -19K | n/a | n/a | n/a | -0.00 |
Shares Outstanding (Basic) | 7.33M | 5.93M | 2.26M | 6.21M | 4.09M | 2.53M | 1.83M | 7.24M | 5.76M | 3.21M | 3.07M | 2.14M | 1.12M | 8.16M | 7.05M | 5.79M | 5.24M | 4.53M |
Shares Outstanding (Diluted) | 7.33M | 5.93M | 2.26M | 6.21M | 4.09M | 2.53M | 1.83M | 7.24M | 5.76M | 3.21M | 3.07M | 2.14M | 1.12M | 8.16M | 7.05M | 5.79M | 5.24M | 4.53M |
EPS (Basic) | -3.86 | -2.84 | -9.77 | -0.23 | -1.93K | -576 | -6.18K | -38.63 | -49.23 | -102.72 | -112 | -135.68 | -244 | -320 | -448 | -320 | -450 | -448 |
EPS (Diluted) | -3.86 | -2.84 | -9.77 | -0.23 | -1.93K | -576 | -6.18K | -38.63 | -49.23 | -102.72 | -112 | -135.68 | -244 | -320 | -448 | -320 | -450 | -448 |
EBITDA | -28.3M | -16.05M | -21.61M | -15.04M | -17.39M | -20.38M | -26M | -27M | -28.08M | -33.01M | -31.89M | -29.34M | -23.23M | -26.37M | -29.45M | -18.52M | -23.55M | -20.73M |
EBIT | -28.27M | -16.83M | -22.11M | -14.21M | -18.36M | -21.35M | -27.33M | -28.15M | -29M | -33.9M | -32.73M | -29.59M | -23.34M | -26.44M | -29.48M | -18.54M | -23.56M | -20.74M |
Depreciation & Amortization | n/a | 493K | 496K | 510K | 1.21M | 1.21M | 1.52M | 978K | 900K | 893K | 836K | 252K | 102K | 63K | 27K | 10K | 7K | 6K |